| Product Information |
|
| Registration Number |
BR-630
|
| Generic Name |
Diphtheria-Tetanus Toxoids And Acellular Pertussis Vaccine, Adsorbed
|
| Brand Name |
Boostrix
|
| Dosage Strength |
Formulation: Each dose (0.5 mL) contains:
Diphtheria toxoid -2.5LF Tetanus toxoid-5.0 Lf Pertussis toxoid-8 mcg Filamentous hemagglutinin (FHA)-8 mcg Pertactin (PRN or 69 kDa OMP)-2.5 mcg
|
| Dosage Form |
0.5 mL Suspension for Injection (IM) - 2PE (See reverse for Formulation)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
0.5 mL Pre-filled Type I Glass Syringe + 2 Sterile
Needles [236 x 1” and 256 x 5/8"] (Box of l’s) (Single Dose)
|
| Pharmacologic Category |
-
|
| Manufacturer |
GlaxoSmithKline Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
|
| Application Type |
-
|
| Issuance Date |
19 February 2021
|
| Expiry Date |
09 September 2025
|